Is the Ketogenic Diet an Effective and Safe Approach to Type 2 Diabetes Management and Weight Loss
touchendocrinology.com/is-th…
@touchENDOCRINE
Have you registered yet to the #CODHyAP Online Congress? Been meaning to and didn't get a chance...
🗓 Saturday, June 6, 2020
🕗 08:00 – 21:00 (China Standard Time)
🎫 REGISTER TODAY at no cost ‼️
🔗 https://teapawt.net/t.co/Xi7JbjR4gT
#RegisterNow #diabetes #obesity #hypertension
The Asia Pacific Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension is going virtual ‼️
🗓 Saturday, June 6, 2020
🕗 08:00 – 21:00 (China Standard Time)
🎫 Free registration, sign up now!
➡️ap.codhy.com/
#Diabetes #Obesity #Hypertension
Obesity increases the risk of developing type 2 diabetes by at least 6 times, regardless of genetic predisposition to the disease, concludes research published in Diabetologia
medicalxpress.com/news/2020-…
CODHy Diabetes, Obesity, Hypertension Congress retweeted
NEW video: Only a common effort can help us meet the challenge of #COVID19. EASD President Professor @SDelprato pays tribute to the work of #diabetes healthcare professionals grappling with the pandemic and outlines how the EASD can support their efforts. easd-elearning.org/covid-19/
On behalf of Prof. Ning Guang and Prof. Itamar Raz, the CODHy family wishes you good fortune in the new year.
#CODHyAP is dedicated to bringing participants the latest advances in #Diabetes, #Obesity and #Hypertension. The Congress speakers represent a variety of expertise and will report on the most up-to-date research and treatments.
Meet the Faculty - https://teapawt.net/t.co/MxScqYAj7r
𝐂𝐎𝐃𝐇𝐲 𝐀𝐬𝐢𝐚 𝐏𝐚𝐜𝐢𝐟𝐢𝐜 𝐒𝐮𝐩𝐩𝐨𝐫𝐭𝐬 𝗪𝐨𝐫𝐥𝐝 𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐃𝐚𝐲
Register within 48 hours to receive a 15% discount
𝐏𝐫𝐨𝐦𝐨𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐝𝐞 𝐂𝐎𝐃𝐇𝐲𝟏𝟓%
#WorldDiabetesDay #CODHyAP2020 #diabetes
https://teapawt.net/t.co/sXj3jB93BN
For men with type 2 #diabetes, the small increased risk for #Fourniergangrene associated with #SGLT2 inhibitor treatment should not dissuade clinicians from prescribing them, according to a research letter published in JAMA Internal Medicine.
Read more: https://teapawt.net/t.co/Jk2fasqvEs
DAPA HF trial: Diabetes drug dapagliflozin provides substantial benefits among patients with chronic HFrEF. ms.spr.ly/6184TOY2a
Share your knowledge and expertise with the CODHy community. Submit your abstract today for poster presentation during CODHy 2020 in Shanghai.
https://teapawt.net/t.co/dMtlKSBr1F
#CODHyAP #diabetes #hypertension #obesity
1
A new study conducted on patients with type 2 #diabetes on #statin therapy revealed the potential benefits of adding an omega-3 supplement. Check out this summary to learn more!
dd4.us/2XpVrki
Mark your calendars! On May 9-10, 2020 in Shanghai, China CODHy will be hosting an unforgettable congress.
Check out ap.codhy.com to receive the latest updates!
#CODHy2020 #Diabetes #Obesity #Hypertension #Shanghai #Savethedate
1
Want $150 off your registration fee? We sure do, act fast as this deal will not last...ONLY 7 days left! 😀
Register here => https://teapawt.net/t.co/THqWFK6sYQ
Use promo: INTCODHYAP2019
#CODHyAP2019 #diabetes #hypertension #obesity
Save $150 when registering before 15 April, 2019 Use promotional code: IntCODHyAP2019 Click the link to register https://teapawt.net/t.co/VIHt2wS39g
#CODHyAP2019 #Shanghai #Diabetes #Hypertension #Obesity
CODHy Diabetes, Obesity, Hypertension Congress retweeted
News: Gap in #cardiovascular risk not closing for people with #type2diabetes, suggests research by Stephanie Read (@EdinburghUni) & colleagues published in @DiabetologiaJnl https://teapawt.net/t.co/4kOYJuzLbM
Do you have knowledge and expertise to share with your colleagues at CODHy 2019?
The 7th World CODHy Congress will raise the most dynamic and controversial topics facing clinicians in the fields of #Diabetes, #Obesity & #Hypertension
Submit today https://teapawt.net/t.co/c4qVyDRQE8















